Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trial.

Autor: Tomazini, Bruno Martins^1,2,3 (AUTHOR) btomazini@hcor.com.br, Tramujas, Lucas¹ (AUTHOR), Medrado Junior, Fernando Azevedo¹ (AUTHOR), Gomes, Samara Pinheiro do Carmo¹ (AUTHOR), Negrelli, Karina Leal¹ (AUTHOR), Murinize, Gabriela Souza¹ (AUTHOR), Santos, Renato Hideo Nakagawa¹ (AUTHOR), Vianna, Bruna Martins Pereira¹ (AUTHOR), Piotto, Bruna Fornazieri¹ (AUTHOR), Veiga, Thabata Silva¹ (AUTHOR), Santos, Bianca Rodrigues do¹ (AUTHOR), Peneluppi Horak, Ana Clara¹ (AUTHOR), Lemos, Olivia Mora Cavalcante⁴ (AUTHOR), Lopes, Marcela de Almeida¹ (AUTHOR), Olicheski, Beatriz Baptista⁴ (AUTHOR), Campones, Diego Lurentt⁴ (AUTHOR), Peixoto, Luiz Angelo Alencar⁴ (AUTHOR), Basilio, Aline dos Anjos Chaves⁴ (AUTHOR), Gebara, Otavio Celso Eluf⁵ (AUTHOR), Lopes, Ana Tarina Alvarez⁵ (AUTHOR)

Publikováno v: PLoS ONE. 2/23/2024, Vol. 19 Issue 2, p1-15. 15p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ninety-day outcomes in patients diagnosed with COVID-19 in São Paulo, Brazil: a cohort study

Autor: Fumis, Renata Rego Lins, Costa, Eduardo Leite Vieira, Tomazini, Bruno Martins, Taniguchi, Leandro Utino, Costa, Livia do Valle, Morinaga, Christian Valle, Sá, Marcia Martiniano de Sousa e, Azevedo, Luciano Cesar Pontes de, Nascimento, Teresa Cristina, Ledo, Carla Bernardes, Oliveira, Maura Salaroli de, Cardoso, Luiz Francisco, Pastore Junior, Laerte, Vieira Junior, José Mauro

Publikováno v: Jornal Brasileiro de Pneumologia, Volume: 49, Issue: 3, Article number: e20230056, Published: 05 JUN 2023

Objective: COVID-19 has been associated with a significant burden to those who survive the acute phase. We aimed to describe the quality of life and symptoms of anxiety, depression, and posttraumatic stress disorder (PTSD) at 90 days after hospital d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______608::9ff6a671644bce7be1e78ddcec43a7a9
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132023000300202&lng=en&tlng=en

A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol.

Autor: Arns, Beatriz, Horvath, Jaqueline Driemeyer C., Rech, Gabriela Soares, Sesin, Guilhermo Prates, Agani, Crepin Aziz Jose Oluwafoumi, da Rosa, Bruna Silveira, dos Santos, Tiago Marcon, Brochier, Liliane Spencer Bittencourt, Cavalcanti, Alexandre Biasi, Tomazini, Bruno Martins, Pereira, Adriano Jose, Veiga, Viviane Cordeiro, Nascimento, Giovana Marssola, Kalil, Andre C., Zavascki, Alexandre P.

Publikováno v: Infectious Diseases & Therapy; Jan2024, Vol. 13 Issue 1, p237-250, 14p